Glycoaminoglycans

Views 507
Jump to
Abstracts Focused Research Topics
Download the GMI DOC on this Topic

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
3 Diseases Researched for Glycoaminoglycans
NameACCKFocus
Amyotrophic Lateral Sclerosis48Locked
Motor Neuron Disease48Locked
Peripheral Neuropathies12Locked
4 Pharmacological Actions Researched for Glycoaminoglycans
NameACCKFocus
Neuroprotective Agents48Locked
Apoptotic12Locked
Neuritogenic12Locked
Neurorestorative12Locked

View the Evidence:
4 Abstracts with Glycoaminoglycans Research

[+]

Co-administration of IGF-I and glycosaminoglycans greatly delays motor neuron disease in the mouse model.Apr 01, 2002

Pubmed Data : J Neurochem. 2002 Apr;81(1):194-202. PMID: 12067233
Article Published Date : Apr 01, 2002
Study Type : Animal Study
Additional Links
Substances : Glycoaminoglycans, Insulin-like Growth Factor (IGF-1)
Diseases : Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Pharmacological Actions : Neuroprotective Agents
[+]

Glycoaminoglycans have neurotrophic and neuroregenerative effects in a mouse model of motor neuron disease.Mar 01, 1998

Pubmed Data : J Neurosci Res. 1998 Mar 1;51(5):559-62. PMID: 9511999
Article Published Date : Mar 01, 1998
Study Type : Animal Study
Additional Links
Substances : Glycoaminoglycans
Diseases : Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Pharmacological Actions : Neuritogenic, Neuroprotective Agents
[+]

Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection, indicating their potential value in motor neuron disease and peripheral neuropathies.Jan 01, 1999

Pubmed Data : Neuroscience. 1999;93(2):565-72. PMID: 10465440
Article Published Date : Jan 01, 1999
Study Type : Animal Study
Additional Links
Substances : Glycoaminoglycans, Insulin-like Growth Factor (IGF-1)
Diseases : Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Peripheral Neuropathies
Pharmacological Actions : Apoptotic, Neuroprotective Agents
Additional Keywords : Drug Synergy
[+]

Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease.Jul 01, 2000

Pubmed Data : Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):339-46. PMID: 10817918
Article Published Date : Jul 01, 2000
Study Type : Animal Study
Additional Links
Substances : Glycoaminoglycans, Insulin-like Growth Factor (IGF-1)
Diseases : Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Pharmacological Actions : Neuroprotective Agents, Neurorestorative
Additional Keywords : Natural Substance Synergy

Copyright: radiantskies / 123RF Stock Photo

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.